Abstract:Background:Bone marrow-derived mesenchymal stem cells (MSCs) have been proved in vitro to inducible differentiate into many kinds of cells of mesenchymal tissues such as osteocytes,chondrocytes, adipocytes,myocytes et al,especially myocardium cells. Recently it was shown that the wall thickness and heart function were improved after MSCs implantation in animal experiments and large-scale clinical trials. But other studies didn’t show that grafted stem cells can bring benefits to heart function in patients with cardiac disease. These therapeutic differences may be rise at least because of lack of visible method to trace in vivo grafted stem cells bio-behaviors such as survive,proliferation,distribution and differentiation. In recent decade an in vivo cellular tracking techniques by using luciferase marker so called BLU have been developed for long-term study of stem cells homing and migration. Bioluminescent imaging ( BLU) technology is a technology to integrate exogenous report luciferase genes into host cells,and express luciferase. This enzyme will give out the visible light when it reacts with its substrate fluorescein under the condition of existing O2 and ATP,to track living cells in real time. In BLU technology the vector for gene transfection is considered a principal because it very closely links to gene transfection efficiency and hence cells lumination. Objective:By using reconstructed-lentivirus vector transfection and bioluminescent imaging techniques to monitor in vivo survival and proliferation and migration of grafted human mesenchymal stem cells (hMSCs) in mice. Methods:Firefly-Luciferase (LUC) -Lentivirus vector were constructed and co-cultured with hMSCs in vitro. Then transfected hMSCs were subcutaneously injected into mice. Either in vitro and in vivo biophotonic imaging of hMSCs were detected by using Xenogen Visible System. Results:1. When multiplicity of infection (MOI) was 100,transfection efficiency of LUC-lentivirus vector could come to (29. 6 ±1. 5)%. Transfected- hMSCs had expressed LUC after 20 successive generation. Indicating this reconstructed lentivirus-LUC-vector has the characteristics of high transfection sensitivity to hMSCs,and high stability for exogenous reporter gene integration and its expression. 2. No morphological and proliferation effect on hMSCs were observed after co- culture with constructed lentivirus vector for 20 generation. This demonstrating that neither lentivirus vector nor exogenous reporter gene has cytotoxicity to targeting cells. 3. Detected in vivo bioluminescence intensity was positively correlated with grafted mass of transfected-LUC hMSCs ( R2 = 0. 9826 ). 4. Since cellular transplantation,in vivo bioluminescence signal bounded injection location were detectable and the signal intensity were linear faded out until to 6th day. Means the survival,homing,proliferation and migration of Firefly-Luciferase gene transfected hMSCs can be quantitatively in vivo monitored in real time. Conclusion: Reconstructed descytotoxicityly lentivirus vector is an effective and safety tool for Firefly-Luciferase gene integrating into hMSCs. Thus by using bioluminescent tracer techniques the phenotype and potential involving homing,proliferation and migration of LUC-transfectied hMSCs can be quantitatively in vivo real-timely monitored.

Tracing of GFP-labeled Stem Cells Transplanted to Discs for Treating Degenerative Discs

Tracing of Bone Marrow Mesenchymal Stem Cells with Green Fluore Scence Protein Labelled in Rabbit Intervertebral Disc

A Study on Transfecting Green Fluorescent Protein Gene to Rat Bone Marrow Mesenchymal Stem Cells

[Study on Multi-Lineage Potential of Bone Marrow Mesenchymal Stem Cells Derived from Green Fluorescent Protein Transgenic Mice].

Experimental Study on the Tracking of Marrow Mesenchymal Stem Cells of Rabbit in Vivo and Therapy for Intervertebral Disc Degeneration

Migration of bone mesenchymal stem cells transplanted in intervertebral disc and expression of exogenous gene

The Rise and Fall of the Trophic and Differentiated Effects in Cell Therapy for Regeneration of Degenerative Intervertebral Discs

[In-Vivo Tracing of Bone Marrow Stromal Cell Differentiating into Chondrocytes by Green Fluorescent Protein Gene Transfection].

In Vivo Tracing of Transplanted Bone Marrow Mesenchymal Stem Cells with Bioluminescence Imaging

Intervertebral disc cell therapy for regenerationand MRI tracer study

The Migration of Bone Marrow Mesenchymal Stem Cells Transplanted into Degenerated Intervertebral Discs Regulated by the Stromal Cell-Derived Factor-1/Chemokine Receptor 4 Axis

Evaluation of intervertebral disc regeneration with implantation of bone marrow mesenchymal stem cells (BMSCs) using quantitative T2 mapping: a study in rabbits

Transplantation of CXCR4 Overexpressed Mesenchymal Stem Cells Augments Regeneration in Degenerated Intervertebral Discs

One-stage Positron Emission Tomography and Magnetic Resonance Imaging to Assess Mesenchymal Stem Cell Survival in a Canine Model of Intervertebral Disc Degeneration.

GFP Labeling and Hepatic Differentiation Potential of Human Placenta-Derived Mesenchymal Stem Cells

Efficacy of CXCR4 over-expressed mesenchymal stem cells in the treatment of intervertebral disc degeneration

Study on the treatment for mouse hindlimb ischemia with green fluorescent protein transgenic mouse adipose-derived stem cells

In Vivo Monitoring of Hmscs Stem Cell by Bioluminescent Tracer in Mice

Microencapsulated bone marrow mesenchymal stem cells marked by superparamagnetic iron oxide allograft to prevent lumbar intervertebral disc degeneration:an experimental research

Transfection of Enhanced Green Fluorescent Protein Gene into Bone Marrow Mesenchymal Stem Cells

Tracking of dual-labeled adipose-derived stem cells in therapying mouse hind-limb ischemia